402 ‒ NMR blood analysis: how mortality risk and more can be assessed from a single blood sample
Peter Attia MD · 2:27:11 · 2 days ago
NMR spectroscopy provides a more accurate assessment of health risk than standard blood panels by measuring the actual number of lipoprotein particles and metabolic markers rather than just mass-based cholesterol levels. This technology enables composite scoring systems, such as the Metabolic Vulnerability Index (MVX), which can track systemic health and mortality risk independently of age or current disease status.
- Particle measurement — Standard lipid panels estimate LDL cholesterol levels using a mathematical formula, which creates inaccuracies; NMR directly measures the number of circulating particles .
- Cardiovascular risk — Higher particle count drives cardiovascular risk regardless of whether particles are "small" or "large"; the idea that large, buoyant LDL is harmless is factually incorrect .
- Diabetes prediction — The LP-IR score aggregates various VLDL, LDL, and HDL sub-classes to identify insulin resistance and diabetes risk well before fasting glucose levels rise .
- Stable inflammation — GlycA, an NMR-derived marker of carbohydrate structures on proteins, provides a stable, long-term assessment of systemic inflammation compared to the highly volatile hs-CRP .
- Mortality forecasting — The Metabolic Vulnerability Index (MVX) combines inflammatory, metabolic, and malnutrition markers to predict mortality risk decades in advance, showing wide variation even in healthy young adults .
- Adoption barriers — Widespread use of NMR diagnostics is limited because health insurance reimbursement models do not prioritize replacing older, less informative tests with more advanced methods .